Bimanual just as safe as coaxial surgery

Article

Removing cataracts using a bimanual microincision technique and implanting a traditional foldable intraocular lens (IOL) through a separate incision causes no more corneal astigmatism compared with a traditional coaxial technique using the same lens, according to a Finnish study.

Removing cataracts using a bimanual microincision technique and implanting a traditional foldable intraocular lens (IOL) through a separate incision causes no more corneal astigmatism compared with a traditional coaxial technique using the same lens, according to a Finnish study.

Kari Krootila and co-workers from Helsinki University Eye Hospital, Finland conducted a randomized study to compare astigmatic changes in bimanual microphacoemulsification compared with coaxial phaco.

In the bimanual microincision group (18 eyes), the cataract was removed through two temporal 1.4 mm incisions. For the IOL implantation, a separate limbal 3 mm incision was made between the two microincisions. In the coaxial group (18 eyes), the cataract was removed using the traditional coaxial technique through a 3 mm temporal limbal incision and one triangular side port incision.

Surgically induced astigmatism (SIA) was 0.89±1.03 D at one day postoperatively and 0.21±0.11 D three months postoperatively in the bimanual group. In the coaxial group, SIA was 0.99±0.89 D at day one and 0.59±0.51 D at three months.

It was concluded that there is little difference in the amount of surgically induced astigmatism between bimanual and coaxial approaches.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.